- News and Events
- ORS Events Calendar
14 May 2013: 2013 Malaria Gordon Research Conference and Seminar
11 March 2013: DMID Expands Its Resources for Vector Researchers
6 February 2013: Research Café
21 January 2013: Prevention, Detection and Management of Arboviral Diseases 2013
14 January 2013: Research Café - Recap of Inaugural Session
3 January 2013: NIH/NIAID Grant: Research in latent tuberculosis infection (LTBI) in
the setting of HIV Co-Infection (R01)
2 January 2013: Grand Challenges: A family of grant programs fostering innovation to solve key global health and development problems
22 November 2012: International Award of the Japanese Association for
Laboratory Animal Science (JALAS) 2012
7 November 2012: Inaugural Meeting of the Mahidol University Stem Cell Network (MU-SCN)
29 October 2012: ‘Meet the Dean’ Speech
29 October 2012: IACUC Training – International Standard Approaches
10 October 2012: Gates Foundation – Grand Challenges Explorations, Round 10
25 September 2012: International Funding Opportunities: Reachable & Sustainable Resources for MU
11 September 2012: Dean’s Research Fund
7 September 2012: ORS Knowledge Meeting – Turnitin
15 August 2012: Bill and Melinda Gates Foundation - Keystone Symposia
15 August 2012: Asia-Pacific Malaria Elimination Program
10 July 2012: TRF-CHE-Scopus Researcher Awards 2012
5 July 2012: Mahidol – Liverpool Symposium 2012
2 July 2012: AXA Postdoctoral Fellowships 2012
29 June 2012: Cell-Free Protein Synthesis Workshop
27 June 2012: NIAID Funding Opportunity
12 June 2012: AXA 2nd Campaign 2012
11 June 2012: Vice-President for Research and team visit Office of Research Services at TropMed
16 May 2012: Wellcome Trust Funding Schemes for Thai/Southeast Asia Researchers
14 May 2012: The Indonesia-Japan-Thailand Joint Forum on Infectious Diseases 2012
6 March 2012: New Grant Opportunities: HIV Vaccine Research and Design (HIVRAD) Program (P01)
Support of multi-component, multi-disciplinary projects that address important scientific questions relevant to AIDS prophylactic vaccine discovery research.
The HIVRAD program is designed to fund projects that further address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. Applications for five years of support should include plans that have advanced past the exploratory stage and include preliminary data. Less fully developed applications can request less than 5 years of support to establish feasibility. Applications aimed at developing or optimizing a specific vaccine platform should lay out a research pathway with clear decision points. Extensive modeling of vaccine concepts in non-human primates may be included.
Clinical studies involving human subjects or vaccine research focused solely on therapeutic applications are not considered appropriate and will not be funded under this FOA.
Letter of intent due date: May 13, 2012
Application budgets are not limited, but need to reflect actual needs of the proposed project.
Award Project Period: Scope of the proposed project should determine the project period. The maximum period is 5 years.
For further information, see: http://grants.nih.gov/grants/guide/pa-files/PAR-12-087.html
6 March 2012: New Grant Opportunities: Partnerships for Development of Vaccine Technologies (R01)
This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects focused on preclinical development of candidate technologies (including adjuvants) that would improve vaccine effectiveness and/or simplify vaccine delivery to patient populations during a natural outbreak of an infectious disease or following the intentional release of an infectious agent. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Letter of intent due date: May 26, 2012
Award budget: Budgets for direct costs of up to $750,000 per year may be requested. In addition, applicants may request up to a total of $300,000 for major equipment in the first year of the award to ensure that research aims can be met and biohazards can be contained.
Scope of the proposed project should determine the project period. The maximum period is 5 years.
For further information, see: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-014.html
6 March 2012: New Grant Opportunities: Grand Challenges Explorations Round 9
Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is now accepting grant proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.
Proposals are being accepted online until May 15, 2012 on the following topics:
- New Approaches for the Interrogation of Anti-malarial Compounds
- Aid is Working. Tell the World
- Design New Approaches to Optimize Immunization Systems
- Explore New Solutions in Global Health Priority Areas
- Protect Crop Plants from Biotic Stresses From Field to Market
(please see this link for more information about each topic: http://www.grandchallenges.org/Explorations/Pages/TopicsOverview.aspx)
Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.
17 Febuary 2012: 15th International Congress on Infectious Diseases (ICID)
The FEBRUARY 2012 issue of the ISID NEWS (the official newsletter of the International Society for Infectious Diseases) is now available online at http://www.isid.org/publications/isid_news/ISIDnewsletter201202.shtml.
An official publication of the International Society for Infectious Diseases
15th International Congress on Infectious Diseases (ICID)
The 15th ICID will be held in Bangkok, Thailand on June 13-16, 2012
The Abstract Submission Deadline has been extended to February 24, 2012.Submit your abstract now!
is also available.
Letter from the Chair of the Local Organizing Committee of the 15th ICID, Bangkok
Treating Hepatitis B in 2012 – C.L. Lai (China)
Finding a Cure for HIV: The Need for Science, Collaboration and Advocacy – S. Lewin (Australia)
Infection Control – D. Pittet (Switzerland)
The Future of Dengue – D. Gubler (Singapore)
Vaccines for Cholera, Shigellosis and Typhoid – J. Clemens (Republic of Korea)
Confronting TB in the Era of HIV – S. Lawn (South Africa)
Updated Scientific Program
For more information, go to http://www.isid.org/icid/symposia.shtml
15th ICID Participating Organizations, Premier Sponsors and Sponsors
Nominations Open for ISID Council
On the occasion of the 15th ICID in Bangkok, more than one-quarter of the ISID Council members will conclude their terms of service and the Society will have openings for Council members from all regions.
The Nominating Committee is actively seeking your recommendations for individuals who are interested in the activities of ISID and who would become involved with the Society in its various programs. Self recommendations are welcome.
ProMED Moderator Chosen as 2012 ICEID Leader
Dr. Joseph Wamala, ProMED moderator for the Anglophone Africa list (ProMEDEAFR), has been selected as an ICEID 2012 Leader to attend the International Conference on Emerging Infectious Diseases (ICEID) March 11-14, 2012 in Atlanta, Georgia, USA.
ProMED-mail 2011 Archives Available for Your Local System
ProMED has received multiple requests from research and academic institutions for faster, more efficient, more flexible searching of the archives. In response to these appeals, we are for the first time offering the complete 2011 database of ProMED-mail postings on a memory stick for access on your local system.
ProMED 2011 Year End Internet-a-thon
ProMED wishes to acknowledge the over 1,000 individuals and institutions who have supported the 2011 Internet-a-thon.
International Meeting on Emerging Diseases (IMED 2013)
The 4th IMED will be held in Vienna, Austria on February 15-18, 2013
Letter from Larry Madoff, Editor, ProMED-mail
For more information, go to http://imed.isid.org/
or Join the IMED 2013 Mailing List
ISID/ESCMID Fellowship Report
Fernanda Ludolf Ribeiro (Brazil)
"Profiling the Humoral Immune Response to Schistosoma mansoni using a New Immunoproteomic Approach—protein microarray."
ISID Grant and Fellowships Programs
Applications open for ISID Grant and Fellowship Programs
Spotlight on the SSI/ISID Fellowship
If you wish to modify your membership status at ISID please contact the Society at firstname.lastname@example.org.
16 Febuary 2012: New Grant Opportunities: ICEMR Training and Career Development Grants in Malaria Research
This program will support skills training and career development of scientists in malaria research from Southeast Asian countries in the Greater Mekong Subregion (Cambodia, China, Laos, Myanmar, Thailand, and Vietnam). This program aims to build local research capacity by providing grant support to postdoctoral scholars and junior faculty on malaria-related topics.
- Antimalarial drug resistance
Process for submission
Applicants should submit a covering letter, current CV, relevant support documents, at least one letter of reference, and up to a 5-page training application. If an applicant is actively employed, a letter from their current employer, chair, or director should also be submitted indicating their support for the required 50% commitment. A final application document (in PDF) should be emailed to Liwang Cui (email@example.com) and Guiyun Yan (firstname.lastname@example.org) by May 31, 2012. For more details, please download the PDF document "ICEMR training", and contact the Office of Research Services for advice and assistance.
19 January 2012: International Society for Infectious Diseases (ISID) Small Grants
The Small Grants Program is designed to fund pilot research projects by young investigators in developing countries. The goal is to support and foster the professional development of young individuals (less than 40 years of age) in the field of human infectious diseases research by helping them to acquire additional skills and data to apply for other grants. Areas of interest include, but are not limited to investigations of the epidemiology, pathophysiology, diagnosis or treatment of infectious diseases, the epidemiology and control of hospital-acquired infections, and modeling of cost effective interventions.
Proposals will be reviewed by members of the Professional Development Working Group and decisions made in collaboration with the President and the Program Director.
Upon completion of the project, a written report of the project must be sent to the Society. The Society encourages recipients of grants to present their results at scientific meetings and to submit them for publication in peer-reviewed journals.
Up to five grants of up to US $6,000
each will be awarded annually. Deadlines for submission of proposals are April 1 (notification after June 1) and October 1 (notification after December 1).
For more information, see: http://www.isid.org/grants/grants_small.shtml
16 January 2012: Medicines for Malaria (MMV) 10th Call for Proposals
MMV welcomes projects in the hits-to-lead stage for new families of molecules specifically addressing the key priorities of the malaria eradication agenda: transmission blocking and prevention of P. vivax relapse. Proposals for chemical series with the potential for P. falciparum chemoprevention or blood stage efficacy as a result of long-half lives are encouraged, though the project should already have initial confirmation of in vivo oral blood stage activity. Early target validation falls outside of our mandate.
In the clinical arena, MMV welcomes proposals for the clinical development of new chemical entities. We have a strong pipeline of new molecules, and so welcome applications regarding capacity building to develop new sites for first-in-patient testing of these new molecules, including both blood stage, transmission blocking and vivax anti-relapse capabilities.
Grant: US$50,000 (10 grants available)
Further instructions and application templates can be found at http://www.mmv.org/research-development/10th-call-proposals
Submissions should be completed on 3 pages of A4. MMV will only receive submissions electronically; please see the templates and contact details on the MMV website.
There are two stages to the process of seeking funding of a project through the Medicines for Malaria Venture. The first stage is a concise 3 page LOI outlining the project using the guidelines and templates provided. These letters will be competitively assessed by MMV and MMV$B!G(Bs Expert Scientific Advisory Committee (ESAC). A short-list of projects will then be invited for the submission of a more detailed proposal, which will be presented and discussed at the MMV offices in Geneva, in a face-to-face meeting (later in 2012) with MMV and MMV ESAC.
MMV funding is highly competitive and it is in your interest to present all relevant data as completely and as concisely as possible.
All applications using the specified templates should be sent electronically to email@example.com
Deadline: 15 March 2012
For more information on MMV grants, see: http://www.mmv.org/newsroom/news/do-you-have-idea-could-revolutionize-malaria-drug-discovery
11 January 2012: AXA Postdoctoral Fellowship Grants
Post-doctoral Fellowship Opportunity
AXA Research Fund
Do you want to attract a high-quality funded Postdoctoral Research Fellow to your center or department?
The AXA Research Fund encourages scientific research that would contribute to understanding and preventing environmental, life, and socio-economic risks. The Fund supports world class research in these areas by providing institutions with the means of attracting and retaining the leading scientists of today and of the next generation. The Fund seeks to support innovative and cutting-edge transdisciplinary projects; particularly as such projects may encounter difficulties in gaining support elsewhere.
- Aging and long term care
- Biomedical risk
- Addictions and risky behaviors
- Geopolitical risks
- Macro-economic and systemic financial risks
- Individual and collective behaviors when facing uncertainties
- Large corporate risks
- Climate change
- Natural hazards
- Human-driven environmental changes
Eligibility: Candidates must be citizens of one of the EU member states, or one of the EU-FP7 countries: i.e. Switzerland, Israel, Norway, Iceland, Liechtenstein, Turkey, Croatia, the Former Yugoslav Republic of Macedonia and Serbia, Albania and Montenegro), or, in Asia (Singapore, Hong Kong, Japan, South Korea, India), or, in Latin America, Brazil and Mexico.
Applicants must apply to undertake their postdoctoral fellowship program at the Faculty of Tropical Medicine, Mahidol University.
Grant: a maximum of €120,000 over 24 months
FIRST-WAVE APPLICATIONS FOR 2012 ARE NOW OPEN
For more information, see http://researchfund.axa.com/post-doctoral-fellowships
For more information, advice, and assistance, contact the Office of Research Services
Telephone Ext 1332
E-mail: firstname.lastname@example.org or email@example.com
11 January 2012: WRAIR Medical Tropical Research Laboratory (MTRLP) Malaria Prevention Research Award (MPRA)
AFRIMS is currently seeking a partner in Cambodia to conduct high quality research to develop new drugs and vaccines to prevent and treat malaria. AFRIMS currently has product candidates in both advanced preclinical and clinical development which may be suitable for licensure. Because drug resistance is the most important threat to effective malaria prevention and treatment, the product development program is combined with antimalarial drug resistance surveillance. Resistance to nearly all currently used antimalarials has been reported in Cambodia, making the development of new effective antimalarials a high public health priority.
Research will be focused on development of new products to include drugs and vaccines, improved use of existing antimalarial drugs, and active epidemiologic surveillance for drug resistance. The research will take place at AFRIMS established clinical research sites and/or facilities within Cambodia, or at new sites approved by the Cambodian Ministry of Health and/or other appropriate authorities.
For more information, please see: here
The deadline is 31 January 2012
, so please act fast! The grant is worth $2,200,000.
5 January 2012: An admiring survey was held for the four IRBs of Mahidol University to discuss and share ethical review protocol
The Center of Ethical Reinforcement for Human Research and representatives of the four Institutional Review Boards of Mahidol University (Siriraj Institutional Review Board, The Committee for Research Ethics (Social Sciences), Ethical Review Committee for Human Research Faculty of Public Health, and Mahidol University Institutional Review Board for Nursing) conducted an admiring survey of the Ethics Committee (EC) of the Faculty of Tropical Medicine (FTM), Mahidol University on 5 January 2012. The objective of this admiring survey was to learn from and share the experiences of the FTM EC experiences. Activities included discussing the FTM EC structure, observing documentation and archiving procedures at the EC office, observing an ethical review meeting, conducting the initial review of a research project, delivering the meeting minutes, reviewing the Committees' CV and SOPs, and interviewing the EC Chairperson, Secretary, Lay-person and Assistant Secretary. Finally, the admiring survey team presented a summary of survey findings.
22 December 2011: Therapeutic antibodies against dengue have been developed at and patented by CEAR
Researchers at the Center of Excellence for Antibody Research (CEAR), Faculty of Tropical Medicine, Mahidol University have successfully developed 11 clones of human monoclonal antibodies using the hybridoma technique with SPYMEG cells. The antibodies are capable of neutralizing all 4 serotypes of the dengue virus with more than 90% efficacy.
These 11 antibody clones have been awarded a patent in the United States (patent number 61/532605). The patent is shared between TropMed inventors, Dr. Pongrama Ramasoota and Dr. Chayanee Setthapramote, and Osaka University researchers, Dr. Kazuyoshi Ikuta, Dr. Tadahiro Sasaki, Dr. Yoshinobu Okuno. Therapeutic applications of these 11 antibody clones will be further investigated by CEAR in futures studies. Currently, there are no approved vaccines for dengue available.
20 December 2011: the XITH EUROPEAN MULTICOLLOQUIUM OF PARASITOLOGY which will be held at Cluj-Napoca, Romania: 25-29 July 2012.
A message of the European Federation of Parasitologists to all Societies of Parasitologists !
Next summer we may have the opportunity to meet again at the XITH EUROPEAN MULTICOLLOQUIUM OF PARASITOLOGY which will be held at Cluj-Napoca, Romania: 25-29 July 2012. Information is available at http://www.zooparaz.net/emop11/index.html.
To stimulate the participation to this event of students and young scientists, the European Federation of Parasitologists (EFP) offers awards and scholarships. These awards and scholarships are granted by the contribution of all European Societies of Parasitologists, members of the EFP.
Student scholarships: The European Federation of Parasitologists grants 25 student scholarships covering the Congress fees. Candidates should be students and nationals of a country attached to European Federation of Parasitologists (see list at http://europfedpar.monsite-orange.fr/page2/index.html ) and participating in an investigation carried out in a European Centre. If you wish to apply for these scholarships, please check the details and conditions at http://www.zooparaz.net/emop11/efp_scholarship_2012.pdf
Young Scientist Awards: The European Federation of Parasitologists also offers 6 Young Scientist Awards. Three prizes (400, 600 & 1000 Û) will be awarded in "Research in Basic Parasitology" and three prizes (400, 600 & 1000 Û) will be awarded "Research in Applied Parasitology". A diploma will be given during the closing ceremony and EMOP registration fees will be refunded. Candidates must be less than 35 years old and be a national of one of the European country members of the EFP. If you wish to apply for these awards, please check the details and conditions at http://www.zooparaz.net/emop11/efp_ysa_2012.pdf.
Looking forward in meeting you soon in Cluj-Napoca !
Pr Jean Dupouy-Camet (1st Vice President of the European Society of Parasitology)
20 December 2011: The First Evaluation Meeting of MOCID Projects was held
The Mahidol-Osaka Center for Infectious Diseases (MOCID), which operates under the Center of Excellence for Antibody Research (CEAR), held its first Evaluation Meeting of research projects. The Meeting was opened by Dr. Tamaki Okabayashi, the Vice Director of MOCID.
Progress reports were delivered for projects entitled: "Generation of mouse monoclonal antibodies specific to tropical diseases," by Dr. Promsin Masrinoul of MOCID; "Co-existence of major and minor viral population from two different origins in patients secondarily-infected with Dengue virus serotype 2 in Bangkok," by Ms. Orapim Puiprom of MOCID; "Epitope mapping of human monoclonal antibodies against dengue virus," by Ms. Chonlatip Pipattanaboon of TropMed; and "In vitro biological interaction of Dengue and Chikungunya viruses co-infection," by Dr. Rutcharin Potiwat of the Department of Medical Entomology; as well as others.
A comprehensive evaluation was given by Dr. Taroh Kinoshita and the Evaluation committee from the Research Institute for Microbial Diseases of Osaka University.
8 December 2011: New Grant Opportunities: Grand Challenges Canada, Rising Stars in Global Health
Rising Stars in Global Health
Grand Challenges Canada is seeking emerging innovators (within 10 years of graduation from a Masters level or PhD) from developing countries. The program is looking for innovative ideas to address complex real world challenges that involve a scientific or technological solution (new or existing) alone or in combination with social and/or business innovations. For more information, please visit http://bit.ly/sFPYsT
This grant opportunity is open until March 23, 2012.
This program aims to tap into the creativity, knowledge and skills of emerging innovators from low- and lower-middle income countries to solve some of the most persistent health challenges in the developing world through scientific/technological, business, and social innovation. We call this approach Integrated Innovation.
We are looking for innovative ideas to address complex real-world challenges that involve a scientific or technological solution (new or existing) alone or in combination with social and/or business innovations.
From a Social Innovation perspective – are there social innovations (including health systems, the determinants of health, ethical/social/cultural/legal frameworks, public policies, leadership and human resources among others) that will be necessary to bring the scientific/technological solutions that are developed to scale in local communities in an appropriate manner?
From a Business Innovation perspective – are there appropriate business systems in place to produce and deliver the scientific/technological solution at an affordable pricepoint?
8 December 2011: New Grant Opportunities: Grand Challenges in Global Health, Achieving Healthy Growth Grant Opportunity
Achieving Healthy Growth Grant Opportunity
Grand Challenges in Global Health is seeking letters of inquiry for the new grant program Discover New Ways to Achieve Healthy Growth. This program will invest US $15 million in research to discover the causes of growth faltering during the first 1000 days of life and to identify effective and affordable interventions to promote healthy growth. For more information, please visit http://www.grandchallenges.org/GrantOpportunities/Pages/healthygrowth.aspx
This grant opportunity will be open until January 25, 2012 at 10:00 a.m. Pacific Standard Time.
The Healthy Growth program will seek to discover new pathways or mechanisms that will aid the development of new interventions to prevent intrauterine growth restriction (IUGR), stunting, and wasting of newborns and infants in the developing world.
A growing body of evidence indicates that the first 1,000 days following conception is a critical window of time for growth and proper function of a wide range of organs and tissues. The developmental environment, which includes nutrients, hormonal signaling, and pathogen exposure has serious consequences for health in infancy, childhood, and later life.
While application of existing interventions is important, universal application during pregnancy and early life in 99 percent of children would only decrease stunting by only one third. Therefore new research is needed to address the underlying biological mechanisms that lead to these adverse developmental outcomes, including examination of the role of infection, inflammation, and nutritional deficiency.
23 November 2011: Tropmed Ethics Committee received renew recognized by SIDCER / FERCAP
The Ethics Committee of the Faculty of Tropical Medicine, Mahidol University was awarded renews recognition by the Strategic Initiative for Developing Capacity in Ethical Review / Forum for Ethical Review Committees in Asia and the Western Pacific Region (SIDCER / FERCAP) for attaining both international and local standards for ethical review The Certificate of Recognition was presented at the 11th FERCAP General Assembly at the Inter-Burgo Hotel, Daegu, South Korea 20-23 November 2011.
20 November 2011: The Faculty of Tropical Medicine investigates the threat of water-borne pathogens in flood-stricken areas
The past few weeks have been some of the most difficult for Thailand, including parts of Bangkok. Floodwaters reached heights of more than 2 meters in several areas and stagnant waters have persisted for over a month. The Faculty of Tropical Medicine, being an institution that specializes in infectious disease and water-borne disease research, sought to assess the risk of contracting such diseases for residents in inundated areas.
Associate Professor Pratap Singhasivanon, the Dean of the Faculty, led a research team that surveyed several districts in Nakhon Pathom. The research team consisted of experts from the Faculty of Tropical Medicine's Departments of Tropical Hygiene, Helminthology, Protozoology, Social and Environmental Medicine and Microbiology and Immunology. Donning chest waders, Dr. Pratap and his team traveled through the flood waters to collect field samples, talked with residents, and observed the flood damage. In addition to testing the flood waters for known water-borne pathogens, Dr. Pratap and his team will also evaluate the likelihood of an outbreak of Anopheles spp. mosquitoes, a known vector of malaria and dengue.
Pictures were provided by Mr. Patiwat Sa-angchai.
20 November 2011: Dr. Jaranit Kaewkungwal, of FTM-BIOPHICS receives BMGF Grand Challenges Explorations Funding
BIOPHICS (Center of Excellence for Biomedical and Public Health Informatics)
Faculty of Tropical Medicine, Mahidol University
420/6 Ratchawithi Road, Bangkok 10400, Thailand
Tel: +66(0)2354 9181-86; Fax: +66(0)2354 9187
BIOPHICS, Faculty of Tropical Medicine, Mahidol University, Thailand,
Receives Grand Challenges Explorations Funding
BANGKOK, THAILAND – BIOPHICS (The Center of Excellence for Biomedical and Public Health Informatics), Faculty of Tropical Medicine, Mahidol University, Thailand, announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. Dr. Jaranit Kaewkungwal will pursue an innovative global health research project, Titled "Cell Phone-Based Vaccination Program for Stateless Children".
Grand Challenges Explorations funds scientists and researchers worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Dr. Jaranit Kaewkungwal's project is one of 108 Grand Challenges Explorations grants announced today.
Projects that are receiving funding show promise in tackling priority global health issues where solutions do not yet exist. This includes finding effective methods to eliminate or control infectious diseases such as polio and HIV as well as discovering new sanitation technologies.
To learn more about Grand Challenges Explorations, visit www.grandchallenges.org.
The main objective of the project is to build an effective mechanism using a cell-phone based solution to achieve the Expanded Program of Immunization (EPI) coverage targets among under-served vulnerable groups. The solution will include two system functionalities on phone-to-phone information sharing for identification and prevention. Identification refers to case registration into the EPI scheme for stateless children, while prevention refers to case management of the receipt of fundamental vaccinations, plus health communications aimed at behavioral change, to improve healthcare-services seeking and access behaviors.
This is a joint project between:
BIOPHICS (Center of Excellence for Biomedical and Public Health Informatics)
Faculty of Tropical Medicine, Mahidol University
420/6 Ratchawithi Road, Bangkok 10400, Thailand
Tel: +66(0)2354 9181-86; Fax: +66(0)2354 9187
BIOPHICS Website: http://www.biophics.org/
Faculty of Tropical Medicine Website: http://www.tm.mahidol.ac.th/eng/index-eng.php
Faculty of Public Health, Mae Fah Luang University
Chiang Rai 57100, Thailand. Tel. +66(0)5391-6027-8; Fax. 66(0)5391-6029
About Grand Challenges Explorations
Grand Challenges Explorations is a US$100 million initiative funded by the Bill & Melinda Gates Foundation. Launched in 2008, Grand Challenge Explorations grants have already been awarded to nearly 500 researchers from over 40 countries. The grant program is open to anyone from any discipline and from any organization. The initiative uses an agile, accelerated grant-making process with short, two-page online applications and no preliminary data required. Initial grants of $100,000 are awarded two times a year. Successful projects have an opportunity to receive a follow-on grant of up to US$1 million.
BIOPHICS is the Center of Excellence for Biomedical and Public Health Informatics, located at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. The goal of the center is to be a resource for both "teaching and reaching" the public with integrity and quality health informatics. The center's mission is not only to serve Thailand's needs, but also to reach out to other countries, especially those in the same tropical environment. It also bridges and networks with other existing centers for knowledge-based and health informatics for truly global health outcomes.
BIOPHICS provides a wide range of development, management, and consulting services to the pharmaceutical industry, biotechnology, academic institutes, and public-health organizations. BIOPHICS has had extensive experience managing clinical databases for several large clinical trials as well as other observational studies and a disease registry. BIOPHICS also undertakes computerized system development for disease surveillance, patient/volunteer tracking, and medical/laboratory data, and conducting and consulting for research studies related to the applications of genetic statistics, bioinformatics, and clinical informatics.
25 October 2011: Dean's Research Fund, Call for Proposals, Round #2, 2011
Due to the recent floods, the application deadline has been extended to 30 November 2011
To promote world-standard research and our core mission, the Faculty of Tropical Medicine has created the Dean's Research Fund, to provide support to promising researchers and research projects. The Dean's Fund Committee is now calling for applications for Round #2 of 2011.
For the Full Announcement <click here>
To download the Application Form <click here>
For further information, please contact Paul Adams or Tim Jackson at the Office of Research Services
Application Deadline: Wednesday, 30 November 2011
23 August 2011: Dean's Research Fund Awardees (Round #1) Announced
The Dean's Research Fund, which is funded through a collaborative and collegial partnership with the Faculty of Tropical Medicine, Mahidol University, and the Wellcome Trust/MORU/Oxford University, was established earlier this year. It aims to expand TropMed's capacity to conduct high-standard, innovative research. After meeting to discuss the applications in June, the Dean's Research Fund Committee decided to fund 6 projects. The awardees and their projects are:
- Dr. Mallika Imwong - Molecular characterization of drug resistance in P. vivax.
- Dr. Pannamthip Pitaksajjakul - Therapeutic and diagnostic human monoclonal antibodies against chikungunya virus.
- Dr. Prakaykaew Charunwatthana - The efficacy of antimalarial treatment for Plasmodium vivax at the Thai-Cambodian border, Thailand.
- Dr. Santi Maneewatchararangsri - Development of an antigen-based immunodiagnostic test for acute febrile illness caused by Leptospira spp.
- Dr. Supatra Thongrungkiat - The effects of different temperatures on the interaction between Aedes mosquitoes and dengue virus, especially viral susceptibility, dissemination, transmission, and disease pathogenesis
- Dr. Wirichada Pan-ngam - Mathematical modeling to design a preparedness plan for the emergence of leptospirosis due to flooding and other environmental changes in Thailand
The award ceremony for the Dean's Research Fund (Round #1, 2011) is scheduled for 31st August 2011. Round #1 is granting a total of 3.45 million Baht to TropMed researchers. The Call for Applications for Round #2 (2011) of the Dean's Research Fund will be announced soon.
16 August 2011: The ORS Hosts Collaboration Partners from the University of South Florida and the Pasteur Institute
During the past month, the Office of Research Services has been the host for several international collaborating parties. As part of a subcontracted project funded by the Gates Foundation, members of the academic and administrative staff of the University of South Florida have been visiting the Faculty of Tropical Medicine. The project's principal investigator, Dr. John Adams, and his team came to
Bangkok to meet with their subcontractee, Dr. Jetsumon Prachumsri, Head of the Mahidol Vivax Research Center. Their visit included traveling to Dr. Jetsumon's field laboratory at the Kanchanaburi Tropical Disease Research Center. The University of South Florida and the Faculty of Tropical Medicine are discussing ways to expand their existing excellent collaborative relationship.
In addition to our partners from the University of South Florida, Dr. Anavaj Sakuntabhai from the Pasteur Institute in Paris, France, visited TropMed to discuss the launch of the EU-supported DENFREE project. The DENFREE project, which will be managed by the ORS, is expected to start in January 2012, with a kick-off meeting on Koh Chang, Thailand.
26 July 2011 TropMed cooperates with JICA and Osaka University to open four new units
TropMed held the opening ceremony for new research facilities, which serve as a manifestation of the collaborative efforts between TropMed and our Japanese partners, including the Japanese International Cooperation Agency (JICA), Osaka University, the Research Foundation for Microbial Diseases of Osaka University (BIKEN), and the Japan Science and Technology Agency (JST). The two-part ceremony consisted of a Buddhist blessing and introductory speeches
by each new unit head in the morning and a series of special scientific lectures in the afternoon.
The four new research units include the following: (1) The Center of Excellence for Antibody Research (CEAR), which will be headed by TropMed's Deputy Dean for Research, Dr. Pongrama Ramasoota; (2) the Mahidol Osaka Center for Infectious Diseases (MOCID), which will be headed by Dr. Kazuyoshi Ikuta from the Osaka University Department of Virology; (3) The Mahidol-JST-JICA Friendship Laboratory; and (4) the BIKEN Endowed Department of Dengue Vaccine Development, which will be headed by Dr. Eiji Konishi, from the Kobe University Graduate School of Medicine Division of Vaccinology.
The scientific seminar portion of the ceremony focused on current advances in monoclonal antibody technology and its uses in dengue treatment, as well as a recounting of achievements that collaboration between TropMed and Osaka University has made possible. With the establishment of these new facilities, TropMed researchers hope new innovations in dengue treatment and antibody technology will be in the near future.
20-22 July 2011 The Ethics Committee travels to Mae Sot to conduct a site visit
As part of its commitment to uphold international standards in research ethics, the EC traveled to the Shoklo Malaria Research Unit (SMRU) in Mae Sot to conduct routine post-approval project monitoring. The SMRU, which was established in 1986, is one of several field stations of TropMed and is also part of the Mahidol-Oxford Research Unit (MORU). The EC's site visit included observing facilities, patient care management, and documentation processes.
The Thai-Myanmar border has historically had a high prevalence of malaria, making it a focus for many malaria control projects and policies. Especially after artemisinin resistance emerged in the region, new research and innovation in this region seems to be the key to carrying out WHO's plans for malaria eradication. The EC went to observe the projects of Dr. François Nosten, who is currently conducting clinical trials for various malaria medications and and in vivo studies on medication resistance.
29 June 2011: Sponsorship for the DENFREE project is confirmed.
The Faculty of Tropical Medicine just received notification of the successful grant submission for the DENFREE project. Dr. Pratap Singhasivanon, Dr. Pattamaporn Kittayapong, Dr. Sutee Yoksan, and Dr. Nuananong Jirakanjanakit are all collaborators on the large-scale, multi-partner project, which includes collaborating organizations from 11 different countries.
The main objectives of DENFREE are (1) to identify key factors determining dengue transmission, outcome of infection and epidemics; (2) the development of less-invasive diagnostic tools to detect asymptomatic infections. Using Asian communities as a model, the risk of dengue emergence into non-endemic areas will be evaluated.
The DENFREE project will last for 4 years. It is funded by the European Commission FP7 program.
27 June 2011: SIDCER/FERCAP representatives come to observe the Faculty of Tropical Medicine Ethics Committee and renews accreditations.
Representatives from the Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP), operating under the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), visited the Faculty of Tropical Medicine Ethics Committee on the 23 June 2011.
The purpose of the visit was to observe the Ethics Committee and confirm that they uphold all international standards for ethical review.
SIDCER/FERCAP representatives observed the EC project review process and offered suggestions for improvement.
All accreditations were renewed for The Faculty of Tropical Medicine EC, allowing them to continue ensuring that all research at the Faculty adheres to international ethical standards. The EC has been accredited with SIDCER/FERCAP since 2008, and is one of only ten recognized accredited ECs/IRBs in Thailand.